Theseus Pharmaceuticals Financials

THRXDelisted Stock  USD 3.71  0.14  3.92%   
Based on the key indicators related to Theseus Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Theseus Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.
  
Understanding current and past Theseus Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Theseus Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Theseus Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Theseus Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Theseus Pharmaceuticals. Check Theseus Pharmaceuticals' Beneish M Score to see the likelihood of Theseus Pharmaceuticals' management manipulating its earnings.

Theseus Pharmaceuticals Stock Summary

Theseus Pharmaceuticals competes with Relay Therapeutics, Century Therapeutics, Blueprint Medicines, Pmv Pharmaceuticals, and Cullinan Oncology. Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Theseus Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS88369M1018
Business Address314 Main Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitetheseusrx.com
Phone857 400 9491
CurrencyUSD - US Dollar

Theseus Pharmaceuticals Key Financial Ratios

Theseus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Theseus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Theseus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Theseus Pharmaceuticals competition to find correlations between indicators driving Theseus Pharmaceuticals's intrinsic value. More Info.
Theseus Pharmaceuticals is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Theseus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Theseus Pharmaceuticals Market Pulse

 Quote3.71
 Change(%)  3.92 
 Change0.14 
 Open3.57
 Low3.52
 High3.87
 Volume0
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Theseus Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Theseus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Theseus Pharmaceuticals' financials are consistent with your investment objective using the following steps:
  • Review Theseus Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Theseus Pharmaceuticals' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Theseus Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Theseus Pharmaceuticals' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Theseus Pharmaceuticals November 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Theseus Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Theseus Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theseus Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Theseus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theseus Pharmaceuticals's daily price indicators and compare them against related drivers.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Theseus Stock

If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities